Trademark: 90533742
Word

Status
Registered
Status Code
700
Status Date
Tuesday, March 21, 2023
Serial Number
90533742
Registration Number
7007043
Registration Date
Tuesday, March 21, 2023
Mark Type
2
Filing Date
Thursday, February 18, 2021
Published for Opposition
Tuesday, April 26, 2022

Trademark Owner History
TAESUNG HEALTHCARE INC - Original Registrant

Classifications
5 Nutraceutical preparations for use as a dietary supplement mainly based on colostrum; health food supplement mainly based on colostrum; products made into chewable tablets based on whey calcium and nonfat dry milk, namely, dietary supplements made into chewable tablets based on whey calcium and nonfat dry milk; ampoule-type health food supplement mainly based on colostrum; nutraceutical preparations for use as a dietary supplement mainly based on whey calcium; nutraceutical preparations for use as a dietary supplement mainly based on calcium ingredient extracted from processed dairy products; health food supplement mainly based on calcium ingredient extracted from processed dairy products; ampoule-type nutraceutical preparations for use as a dietary supplement mainly based on calcium ingredient extracted from milk; ampoule-type health food supplement mainly based on calcium ingredient extracted from milk; nutraceutical preparations for use as a dietary supplement mainly based on mineral extracted from milk products; health food supplement mainly based on mineral extracted from milk products; nutraceutical preparations for use as a dietary supplement mainly based on vitamin extracted from milk products; health food supplement mainly based on vitamin extracted from milk products; nutraceutical preparations for use as a dietary supplement mainly based on calcium ingredient extracted from milk; nutraceutical preparations for use as a dietary supplement mainly based on calcium ingredient extracted from milk and containing vitamins; chewable-type lactic acid bacteria tablets being probiotic supplements; health food supplement mainly based on fruits; health food supplement mainly based on vegetables; health food supplement mainly based on collagen; health food supplement mainly based on pomegranate extracts
The mark consists of Korean characters.
The non-Latin characters in the mark transliterate to “PEU-RE-MIL CHYU-EO-BEUL” and this means “FREMEAL CHEWABLE” in English.
THE NON-LATIN CHARACTERS THAT TRANSLITERATE TO "CHYU-EO-BEUL"

Trademark Events
Sep 27, 2021
Non-Final Action E-Mailed
Feb 22, 2021
New Application Entered
May 19, 2021
New Application Office Supplied Data Entered
May 20, 2021
Notice Of Design Search Code E-Mailed
Sep 14, 2021
Assigned To Examiner
Sep 27, 2021
Non-Final Action Written
Sep 27, 2021
Notification Of Non-Final Action E-Mailed
Mar 24, 2022
Previous Allowance Count Withdrawn
Mar 24, 2022
Approved For Pub - Principal Register
Mar 24, 2022
Examiners Amendment -Written
Mar 24, 2022
Examiners Amendment E-Mailed
Mar 24, 2022
Notification Of Examiners Amendment E-Mailed
Mar 24, 2022
Examiner's Amendment Entered
Mar 24, 2022
Approved For Pub - Principal Register
Apr 6, 2022
Notification Of Notice Of Publication E-Mailed
Apr 26, 2022
Published For Opposition
Apr 26, 2022
Official Gazette Publication Confirmation E-Mailed
Jun 21, 2022
Noa E-Mailed - Sou Required From Applicant
Dec 19, 2022
Teas Statement Of Use Received
Dec 19, 2022
Use Amendment Filed
Jan 21, 2023
Case Assigned To Intent To Use Paralegal
Jan 21, 2023
Statement Of Use Processing Complete
Feb 11, 2023
Allowed Principal Register - Sou Accepted
Feb 14, 2023
Notice Of Acceptance Of Statement Of Use E-Mailed
Mar 21, 2023
Registered-Principal Register
Mar 21, 2023
Notice Of Registration Confirmation Emailed
Sep 10, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 10, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 10, 2024
Teas Change Of Correspondence Received
Sep 10, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 10, 2024
Teas Change Of Correspondence Received
Sep 10, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Trademark Alertz updated from USPTO on 2030-01-24